A Trial of HRS-5965 Capsule in Primary IgA Nephropathy

HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia

NCT04925661 ·Status: COMPLETED ·Phase: PHASE1

Evaluate the Efficacy and Safety of SHR1459 Tablets in Patients With Primary Membranous Nephropathy

NCT05136456 ·Status: UNKNOWN ·Phase: PHASE2

A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.

NCT06470191 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy

NCT03643965 ·Status: COMPLETED ·Phase: PHASE3

Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients

NCT04578834 ·Status: COMPLETED ·Phase: PHASE3

Study of Telitacicept in Patients With Refractory IgA Nephropathy

NCT05596708 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

A Study of HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function

NCT07322016 ·Status: RECRUITING ·Phase: PHASE1

A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy

NCT06676007 ·Status: RECRUITING

A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

NCT06963827 ·Status: RECRUITING ·Phase: PHASE3

A Study to Evaluate the Effectiveness and Safety of IONIS-FB-LRx, an Antisense Inhibitor of Complement Factor B, in Adult Participants With Primary IgA Nephropathy

NCT04014335 ·Status: COMPLETED ·Phase: PHASE2

Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function

NCT06039254 ·Status: UNKNOWN ·Phase: PHASE1

Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor

NCT00437463 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD

NCT05510323 ·Status: RECRUITING ·Phase: PHASE3

Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy

NCT02662283 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation

NCT03373461 ·Status: COMPLETED ·Phase: PHASE2

Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis.

NCT04925674 ·Status: COMPLETED ·Phase: PHASE1

Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With IGA Nephropathy on Stable RAAS Blockade

NCT02384317 ·Status: COMPLETED ·Phase: PHASE2

Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy

NCT07289763 ·Status: RECRUITING ·Phase: PHASE2

A Study With Imlifidase in Anti-GBM Disease

NCT05679401 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Safety of HRS-1780 Tablets and Henagliflozin Proline Tablets in Patients With Chronic Kidney Disease

NCT06221059 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis

NCT05517980 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study to Evaluate the Pharmacokinetics of HSK21542 in Subjects With Renal Impairment

NCT05947097 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Assess S-217622 in Participants With Renal Impairment and Healthy Participants

NCT05363215 ·Status: COMPLETED ·Phase: PHASE1

Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy

NCT01758120 ·Status: UNKNOWN ·Phase: PHASE4

A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy

NCT05174221 ·Status: COMPLETED ·Phase: PHASE1